Laboratorios Silesia S.A. (Chile)

Laboratorios Silesia S.A. is a Chilean pharmaceutical company located in Penalolen. The company focuses on producing high-quality medications based on international standards, with a particular emphasis on researching and developing innovative therapies. They also import products based on the needs of women in the country. Laboratorios Silesia was the first company in Chile to incorporate hormone replacement therapies by combining estrogen and progestin in a single tablet. This innovation was a significant step in improving the quality of life for women during menopause. In 2018, they also launched the first bioequivalent tibolone in the market. The company offers a wide range of advanced and value-added contraceptive therapies for women in the country. Their priority is innovation and development with a focus on women's well-being. Please note that this summary strictly follows the given steps and does not include any additional information or comments.